S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
NASDAQ:NEPH

Nephros - NEPH Stock Forecast, Price & News

$0.91
-0.04 (-4.21%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.91
$0.97
50-Day Range
$0.91
$1.87
52-Week Range
$0.91
$8.51
Volume
11,590 shs
Average Volume
58,695 shs
Market Capitalization
$9.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.63

Nephros MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
1,067.6% Upside
$10.63 Price Target
Short Interest
Healthy
0.28% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.18mentions of Nephros in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.50) to ($0.19) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars

NEPH stock logo

About Nephros (NASDAQ:NEPH) Stock

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Receive NEPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter.

NEPH Stock News Headlines

Nephros Appoints Joe Harris to Its Board of Directors
Nephros, Inc. Tops Q2 EPS by 2c
Nephros: Q2 Earnings Insights
Nephros Unveils New Branding and Website
Nephros to Present at Q1 Virtual Investor Summit
Nephros reports Q4 results
Nephros: Q4 Earnings Insights
See More Headlines
Receive NEPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter.

NEPH Company Calendar

Last Earnings
8/10/2022
Today
10/02/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NEPH
Employees
34
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.63
High Stock Price Forecast
$16.00
Low Stock Price Forecast
$5.25
Forecasted Upside/Downside
+1,067.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-4,110,000.00
Pretax Margin
-50.68%

Debt

Sales & Book Value

Annual Sales
$10.40 million
Book Value
$1.44 per share

Miscellaneous

Free Float
9,432,000
Market Cap
$9.39 million
Optionable
Not Optionable
Beta
1.21

Key Executives

  • Mr. Andrew  AstorMr. Andrew Astor (Age 65)
    CEO, CFO, Pres & Director
    Comp: $378.62k
  • Mr. Wesley S. LoboMr. Wesley S. Lobo (Age 45)
    Chief Commercial Officer
    Comp: $395.66k
  • Ms. Joleen C. Turner
    VP of Marketing & Bus. Devel.
  • Mr. Shane Sullivan
    VP of Sales
  • Vashone R. Thomas
    VP of Quality, Regulatory, & HR
  • Mr. Daron G. Evans (Age 48)
    Chief Exec. Officer of Specialty Renal Products, Inc
  • Mr. Greg Lucas
    Pres of Aether Water Systems













NEPH Stock - Frequently Asked Questions

Should I buy or sell Nephros stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nephros in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NEPH shares.
View NEPH analyst ratings
or view top-rated stocks.

What is Nephros' stock price forecast for 2022?

3 brokerages have issued 1 year price objectives for Nephros' stock. Their NEPH share price forecasts range from $5.25 to $16.00. On average, they predict the company's share price to reach $10.63 in the next year. This suggests a possible upside of 1,067.6% from the stock's current price.
View analysts price targets for NEPH
or view top-rated stocks among Wall Street analysts.

How have NEPH shares performed in 2022?

Nephros' stock was trading at $5.90 at the start of the year. Since then, NEPH stock has decreased by 84.6% and is now trading at $0.91.
View the best growth stocks for 2022 here
.

When is Nephros' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our NEPH earnings forecast
.

How were Nephros' earnings last quarter?

Nephros, Inc. (NASDAQ:NEPH) issued its earnings results on Wednesday, August, 10th. The company reported ($0.12) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by $0.02. The company had revenue of $2.88 million for the quarter, compared to analysts' expectations of $2.70 million. Nephros had a negative net margin of 50.68% and a negative trailing twelve-month return on equity of 37.94%.

What guidance has Nephros issued on next quarter's earnings?

Nephros issued an update on its second quarter 2022 earnings guidance on Wednesday, August, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.90 million-$2.90 million, compared to the consensus revenue estimate of $2.52 million.

What is Nephros' stock symbol?

Nephros trades on the NASDAQ under the ticker symbol "NEPH."

How do I buy shares of Nephros?

Shares of NEPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nephros' stock price today?

One share of NEPH stock can currently be purchased for approximately $0.91.

How much money does Nephros make?

Nephros (NASDAQ:NEPH) has a market capitalization of $9.39 million and generates $10.40 million in revenue each year. The company earns $-4,110,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

How can I contact Nephros?

Nephros' mailing address is 380 LACKAWANNA PLACE, SOUTH ORANGE NJ, 07079. The official website for the company is www.nephros.com. The company can be reached via phone at (201) 343-5202, via email at ksmith@pcgadvisory.com, or via fax at 201-343-5207.

This page (NASDAQ:NEPH) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.